RSPN vs. BIS
Compare and contrast key facts about Invesco S&P 500® Equal Weight Industrials ETF (RSPN) and ProShares UltraShort Nasdaq Biotechnology (BIS).
RSPN and BIS are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. RSPN is a passively managed fund by Invesco that tracks the performance of the S&P 500® Equal Weight Industrials Index. It was launched on Jan 11, 2006. BIS is a passively managed fund by ProShares that tracks the performance of the NASDAQ Biotechnology Index (-200%). It was launched on Apr 7, 2010. Both RSPN and BIS are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RSPN or BIS.
Performance
RSPN vs. BIS - Performance Comparison
Returns By Period
In the year-to-date period, RSPN achieves a 24.13% return, which is significantly higher than BIS's -0.78% return. Over the past 10 years, RSPN has outperformed BIS with an annualized return of 11.53%, while BIS has yielded a comparatively lower -21.22% annualized return.
RSPN
24.13%
1.68%
13.26%
34.82%
15.06%
11.53%
BIS
-0.78%
14.98%
3.75%
-26.18%
-20.96%
-21.22%
Key characteristics
| RSPN | BIS | |
|---|---|---|
| Sharpe Ratio | 2.48 | -0.68 |
| Sortino Ratio | 3.51 | -0.85 |
| Omega Ratio | 1.43 | 0.91 |
| Calmar Ratio | 5.99 | -0.25 |
| Martin Ratio | 14.52 | -0.83 |
| Ulcer Index | 2.38% | 29.57% |
| Daily Std Dev | 13.92% | 35.92% |
| Max Drawdown | -61.64% | -99.77% |
| Current Drawdown | -3.38% | -99.72% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RSPN vs. BIS - Expense Ratio Comparison
RSPN has a 0.40% expense ratio, which is lower than BIS's 0.95% expense ratio.
Correlation
The correlation between RSPN and BIS is -0.51. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Risk-Adjusted Performance
RSPN vs. BIS - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RSPN vs. BIS - Dividend Comparison
RSPN's dividend yield for the trailing twelve months is around 0.88%, less than BIS's 3.72% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
RSPN Invesco S&P 500® Equal Weight Industrials ETF | 0.88% | 0.55% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BIS ProShares UltraShort Nasdaq Biotechnology | 3.72% | 1.75% | 0.00% | 0.00% | 0.44% | 2.10% | 0.37% |
Drawdowns
RSPN vs. BIS - Drawdown Comparison
The maximum RSPN drawdown since its inception was -61.64%, smaller than the maximum BIS drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for RSPN and BIS. For additional features, visit the drawdowns tool.
Volatility
RSPN vs. BIS - Volatility Comparison
The current volatility for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) is 5.18%, while ProShares UltraShort Nasdaq Biotechnology (BIS) has a volatility of 13.19%. This indicates that RSPN experiences smaller price fluctuations and is considered to be less risky than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.